Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA1NR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $75,383
Award facts
- Contract value 100% obligated
- $75,382.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $75,382.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on January 29, 2026, with an ultimate completion date of January 30, 2026. This is an unset-aside contract, meaning it was competed on a full and open basis. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company being Cencora, Inc. (doing business as AmerisourceBergen). Dupixent is a specialty biologic medication used to treat atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps, reflecting the government's procurement of critical pharmaceutical products for military and federal healthcare systems.
This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at up to $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies globally to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. The company's extensive federal contract portfolio and capability to fulfill specialized pharmaceutical procurement requirements through competitive processes demonstrates its critical role in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FA1NR?
SPE2DR26FA1NR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FA1NR worth?
The government has obligated $75,383 on SPE2DR26FA1NR.
Is contract SPE2DR26FA1NR an order under another contract?
Yes. SPE2DR26FA1NR is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA1NR competed?
The extent of competition for SPE2DR26FA1NR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award